samedan logo

 
 
spacer
home > ebr > spring 2003 > the development of parp inhibitors to treat cancer and other diseases
PUBLICATIONS
European Biopharmaceutical Review

The Development of PARP Inhibitors to Treat Cancer and Other Diseases

There is currently much debate in the pharmaceutical industry regarding the future of cancer treatment. Only time will tell if research into anti-angiogenesis, vaccines, monoclonal antibodies and myriad signalling pathways, among other therapeutic strategies, will provide returns on investment and significantly improve the treatment of cancer. At the same time, the knowledge gained from current cancer research and targeted drug discovery programmes must be viewed in light of the opportunities that it may offer for treating other important human diseases. It is important to realise that vast libraries of compounds are generated during the course of the cancer drug discovery process and many of these may have uses in disease areas that do not strategically fit with the goals and focus of the developer.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Professor Stephen P Jackson, Deputy Chairman of the Wellcome Trust/Cancer Research UK Institute of Cancer and Developmental Biology, and Founder of KuDOS Pharmaceuticals Ltd

Professor Stephen P Jackson is Deputy Chairman of the Wellcome Trust/Cancer Research UK Institute of Cancer and Developmental Biology, and is the Frederick James Quick Professor of Biology at the University of Cambridge. He founded KuDOS Pharmaceuticals Ltd together with Cancer Research Technology and the University of Cambridge in 1997.

In 2002, Professor Jackson was awarded the Anthony Dipple Carcinogenesis Young Investigators' Award for his contributions in the field of molecular oncology, and in 1997 he received both the Tenovus Medal and the Biochemical Society Colworth Medal. He has also been elected a member of the European Molecular Biology Organization. He holds a PhD in molecular biology from the University of Edinburgh.

spacer
Professor Stephen P Jackson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Finalists revealed for CPhI Worldwide’s eagerly anticipated 2019 Awards

London, 17th October 2019: CPhI Worldwide announces the finalists for the CPhI Pharma Awards. The shortlist spans 13 different categories across the full spectrum of the pharmaceutical supply chain, including Formulation, Packaging and Lifetime Achievement Awards.
More info >>

White Papers

Data Technology as a Catalyst for Growth in the Life Sciences

AIGENPULSE

The life sciences industry is changing at a rapid pace. The need to develop the next blockbuster is pushing current technologies and methodologies to the limit. Scientific advancement over the last decades was embossed with giant leaps in knowledge, however, the new reality is that smaller incremental gains need to be carved out with ever increasing investments. In order to survive, progress and prosper in this new reality, a holistic approach to getting the most of research data is crucial. In fact, it will likely be the difference of being in existence in 5-10 years or not. For those bold enough to step into an area they are unfamiliar with, huge rewards are waiting.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

23-26 March 2020, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 23 – 26 March 2020. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement